Nanjing Harbin Pharmaceutical Technology Co., Ltd
Nanjing Habo focuses on R&D of new pharmaceutical intermediates, promoting IP in China through integration of research, development, production, and customization.
Introduction
Nanjing Habo Pharmaceutical Technology Co., Ltd. specializes in the research and development of innovative pharmaceutical intermediates, driving the advancement of pharmaceutical technology with unique intellectual property in China. The company seamlessly integrates scientific research, development, production, and customization to ensure a comprehensive and efficient approach to pharmaceutical innovation.
Information
More Websites
Specializes in mass transfer products and services for oil refining and petrochemical industries.
Xuancheng Jingrui New Materials Co., Ltd. is a high-tech nanotechnology company with 130 R&D professionals.
Agno Pharma is a global CRO & CMO with an FDA-approved, multi-certified API manufacturing facility in China.